Comparison of Adenosine Stress Myocardial Perfusion Scintigraphy and Oral Dipyridamole Stress Myocardial Perfusion Scintigraphy for Hemodynamic Changes and Adverse Effects

Year 2016, Volume: 17 Issue: 2, 90 - 97, 01.08.2016

Ahmet Yanarateş Filiz Hatipoğlu Ayşegül Akgün Kamil Kumanlıoğlu

Abstract

Objective: Similar effects can be achieved during stress myocardial perfusion scintigraphy (MPS) using pharmacological agents to create cardiac stress for patients who are unable to exercise. In our study, we aimed to show the hemodynamic changes and adverse effects caused by adenosine and to compare the results with dipyridamole stress MPS. Materials and Methods: Sixty-five patients with suspected coronary artery disease were included in our study. Fifty patients in whom stress MPS with intravenous adenosine was performed (group A) and 15 patients who underwent oral dipyridamole stress MPS (group B) were retrospectively evaluated. During the test, blood pressure measurements and electrocardiographic follow-up were performed in all patients and side effects were noted. Results: At least one side effect occurred in 68% of the group A and in 46% of the group B patients. There was no statistically significant difference between the two groups in terms of side effects that occurred during the pharmacological stress. During the maximum stress, there was an increase of 15.80±11.60 beats/min in heart beats in group A and 5.53±4.54 beats/min in group B. There was a statistically significant difference between the groups in terms of heart rate increase per minute. When we compared reduction in systolic blood pressure and diastolic blood pressure, there was no statistically significant difference between the two groups. Conclusion: Although side effects are more often seen with adenosine, rapid decline in complaints was observed when adenosine infusion was terminated and there was no need for patient follow-up due to short half life of adenosine. We believe that these favourable advantages will increase the use of adenosine in clinical practice.

Keywords

Myocardial perfusion scintigraphy, adenosine, dipyridamole

İntravenöz Adenozin ve Oral Dipiridamol ile Miyokard Perfüzyon Sintigrafisi Uygulanan Hastalarda Hemodinamik Değişiklikler ile Yan Etkilerin Karşılaştırılması

Abstract

-

Keywords

Miyokard perfüzyon sintigrafisi, adenozin, dipiridamol

References

• 1. Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of patients withcoronary artery disease. Circulation 2000; 101: 1465-78.
• 2. Samady H, Wackers FJ, Joska TM, Zaret BL, Jain D. Pharmacologic stress perfusion imaging with adenosine: role of simultaneous low-level treadmill exercise. J Nucl Cardiol 2002; 9: 188-96.
• 3. Travain MI, Wexler JP. Pharmacological stress testing. Semin Nucl Med 1999; 29: 298-318.
• 4. Leppo JA. Dipyridamole-thallium imaging: the lazy man’s stress test. J Nucl Med 1989; 30: 281-7.
• 5. Guyton AC. Text book of Medical Physiology. Koroner dolaşım ve iskemik kalp hastalığı. 7 th ed. WB Saunders: Nobel Tıp Kitabevi, 1986: 423-30.
• 6. Gupta NC, Esterbrooks DJ, Hilleman DE, Mohiuddin SM. Comparison of adenosine and exercise thallium-201 singlephoton emission computed tomography (SPECT) myocardial perfusion imaging. The GE SPECT Multicenter Adenosine Study Group. J Am Coll Cardiol 1992; 19: 248-57.
• 7. Picano E, Lattuzi F, Masini M, Distante A, L’Abbate A. High dose dipyridamole echocardiography test in effort angina pectoris. J Am Coll Cardiol 1986; 8: 848-54.
• 8. Henzlova MJ, Cerqueira MD, Hansen CL, Taillefer R, Yao S. ASNC, Imaging guidelines for nuclearcardiology procedures, Stress protocols and tracers. J Nucl Cardiol 2009. https://static-content. springer.com/esm/art%3A10.1007%2Fs12350-009-9062-4/ MediaObjects/12350_2009_9062_MOESM1_ESM.pdf
• 9. Gordon L, Hendrix GH. The use of pharmacological agents in myocardial perfusion imaging. In: Freeman LM, editor. Nuclear medicine annual 1994. Philadelphia: Lippincott Williams and Wilkins, 1994; 121-40.
• 10. Kubo S, Tadamura E, Toyoda H, Mamede M, Yamamuro M, Magata Y, et al. Effect of caffeine intake on myocardial hyperemic flow induced by adenosine triphosphate and dipyridamole. J Nucl Med 2004; 45: 730-8.
• 11. Zaret BL, Wackers FJ. Nuclear cardiology (1). N Eng J Med 1993; 329: 775-83.
• 12. Taillefer R, Amyot R, Turpin S, Lambert R, Pilon C, Jarry M. Comparison between dipyridamole and adenosine as pharmacologic coronary vasodilators in detection of coronary artery disease withthallium 201imaging. J Nucl Cardiol 1996; 3: 204-11.
• 13. Biaggioni I, Killian TJ, Mosqueda-Garcia R, Robertson RM, Robertson D. Adenosine increasessympathetic nerve traffic in humans. Circulation 1991; 83: 1668-75.
• 14. Knabb RM, Gidday JM, Ely SW, Rubio R, Berne RM. Effects of dipyridamole on myocardial adenosine and active hyperemia. Am J Physiol 1984; 247: 804-10.
• 15. Iskandrian AS, Verani MS, Heo J. Pharmacologic stress testing: mechanism of action, hemodynamic responses and results in detection of coronary artery disease. J Nuc Cardiol 1994; 1: 94- 111.
• 16. Cerqueire MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Safety profile of adenosine stress perfusion imaging: results from the adenoscan multicenter trial registry. J Am Coll Cardiol 1994; 23: 384-9.
• 17. Granato JE, Watson DD, Beladinelli L, Cannon JM, Beller GA. Effects of dipyridamole and aminophylline and hemodynamics, regional myocardial blood flow and thallium-201 washout in the setting of a critical coronary stenosis. J Am Coll Cardiol 1990; 16: 1760-70.
• 18. Johnston DL, Daley JR, Hodge DO, Hopfenspirger MR, Gibbons RJ. Hemodynamic responses and adverse effects associated with adenosine and dipyridamole pharmacologic stress testing: a comparison in 2,000 patients. Mayo Clin Proc 1995; 70: 331-6.
• 19. Verani MS, Mahmarian JJ, Hisson JB, Boyce TM, Staudacher RA. Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patiens unable to exercise. Circulation 1990; 82: 80-7.
• 20. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990; 86: 228-34.